JENNIFER BATTISTE: Open Payments
NPI 1629021985 · CALEDONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 68 payments from 18 companies in 2025. Trend: 2023 $1,270 · 2024 $1,723 · 2025 $1,269
Food & beverage: $1,209Education: $60
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $294 |
| AstraZeneca Pharmaceuticals LP | 10 | $191 |
| Lilly USA, LLC | 7 | $159 |
| GlaxoSmithKline, LLC. | 11 | $150 |
| PFIZER INC. | 5 | $106 |
| Astellas Pharma US Inc | 2 | $85 |
| Amgen Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $41 |
| Exact Sciences Corporation | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Wegovy, AIRSUPRA, Ozempic, MOUNJARO, TRELEGY ELLIPTA, OTEZLA, PREVNAR 20, QULIPTA.
Industry payments across MI — which companies pay providers there.
